Amneal Pharmaceuticals (AMRX) Return on Capital Employed Growth (3y) (2021 - 2026)
Amneal Pharmaceuticals (AMRX) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 607.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 607.00 |
| Mar 31, 2026 | 1,451.00 |
| Dec 31, 2025 | 1,481.00 |
| Sep 30, 2025 | 1,806.00 |
| Jun 30, 2025 | 2,180.00 |
| Mar 31, 2025 | 1,206.00 |
| Dec 31, 2024 | 595.00 |
| Sep 30, 2024 | 300.00 |
| Jun 30, 2024 | 328.00 |
| Mar 31, 2024 | 368.00 |
| Dec 31, 2023 | 475.00 |
| Sep 30, 2023 | 977.00 |
| Jun 30, 2023 | 1,216.00 |
| Mar 31, 2023 | 376.00 |
| Dec 31, 2022 | 741.00 |
| Sep 30, 2022 | 131.00 |
| Jun 30, 2022 | -494.00 |
| Mar 31, 2022 | 794.00 |
| Dec 31, 2021 | 516.00 |
| Sep 30, 2021 | 391.00 |